tiprankstipranks
Trending News
More News >
Argenica Therapeutics Ltd (AU:AGN)
ASX:AGN
Australian Market

Argenica Therapeutics Ltd (AGN) Income Statement

Compare
12 Followers

Argenica Therapeutics Ltd Income Statement

Last quarter (Q4 2025), Argenica Therapeutics Ltd's total revenue was AU$379.87K, an increase of 2.12% from the same quarter last year. In Q4, Argenica Therapeutics Ltd's net income was AU$-5.98M. See Argenica Therapeutics Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 3.21MAU$ 2.60MAU$ 0.00AU$ 259.10KAU$ 296.07K
Gross Profit
AU$ 3.21MAU$ 2.60MAU$ 1.75MAU$ 259.10KAU$ 296.07K
Operating Expenses
AU$ 10.90MAU$ 8.27MAU$ 6.62MAU$ 4.35MAU$ 1.33M
Depreciation and Amortization
AU$ 7.68MAU$ 5.67MAU$ 4.87MAU$ 4.09MAU$ 0.00
EBITDA
AU$ 0.00AU$ -1.90MAU$ -4.81MAU$ -4.09MAU$ -1.33M
Operating Income
AU$ -7.68MAU$ -5.67MAU$ -6.62MAU$ -4.09MAU$ -1.03M
Other Income/Expenses
AU$ 512.25KAU$ -1.90MAU$ 431.93KAU$ 1.68KAU$ 182.00
Pretax Income
AU$ -7.17MAU$ -7.57MAU$ -6.19MAU$ -4.09MAU$ -1.03M
Net Income
AU$ -7.17MAU$ -5.48MAU$ -4.82MAU$ -4.09MAU$ -1.03M
Per Share Metrics
Basic EPS
AU$ -0.06AU$ -0.05AU$ -0.06AU$ -0.06AU$ -0.01
Diluted EPS
AU$ -0.06AU$ -0.05AU$ -0.06AU$ -0.06AU$ -0.01
Weighted Average Shares Outstanding
127.53M 103.39M 87.58M 73.93M 73.17M
Weighted Average Shares Outstanding (Diluted)
127.53M 103.71M 87.58M 73.93M 73.17M
Currency in AUD

Argenica Therapeutics Ltd Earnings and Revenue History